Chengcheng Liu

Efficacy of first-line treatments in the elderly and non-elderly patients with advanced epidermal growth factor receptor mutated, non-small cell lung cancer: a network meta-analysis

P. Xing, Junling Li, Ziyi Xu, 2022, BMC cancer.

Limited role of KRAS mutation in guiding immunotherapy in advanced non-small-cell lung cancer.

Yan Wang, Chengming Liu, Chengcheng Liu, 2022, Future oncology.

Cost‐effectiveness of risk‐tailored screening strategy for colorectal cancer: A systematic review

Youqing Wang, Le Wang, Chengcheng Liu, 2022, Journal of gastroenterology and hepatology.

Front-Line Therapy in EGFR Exon 19 Deletion and 21 Leu858Arg Mutations in Advanced Non-Small Cell Lung Cancer: A Network Meta-Analysis

P. Xing, Junling Li, Le Wang, 2021, Evidence-based complementary and alternative medicine : eCAM.

A Randomized Phase III Study of Anlotinib Versus Bevacizumab in Combination With CAPEOX as First-Line Therapy for RAS/BRAF Wild-Type Metastatic Colorectal Cancer: A Clinical Trial Protocol

Ying Cheng, E. Li, Yanqiao Zhang, 2023, Technology in cancer research & treatment.

One-step percutaneous transhepatic cholangioscopic lithotripsy in patients with choledocholithiasis.

Ping Wang, Haisu Tao, Xinghua Zhou, 2021, Clinics and research in hepatology and gastroenterology.